DVL2 and colitis: Tang et al. [143] focused on the role of DVL2 in colitis-associated colorectal cancer (CAC) and found that DVL2 interacted with TNF receptor 1 (TNFRI), facilitating its endocytosis and inhibiting NF-κB signaling.